{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:38:35Z","timestamp":1778845115608,"version":"3.51.4"},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The National Institutes of Health remain committed to ending HIV in the United States by 2030 through a combination of implementation science, public and private partnerships, community engagement, federal agency collaborations, and a comprehensive research portfolio that includes basic science.<\/jats:p>","DOI":"10.1093\/infdis\/jiag062","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:41:04Z","timestamp":1769776864000},"page":"e1092-e1093","source":"Crossref","is-referenced-by-count":0,"title":["Future Directions for NIH HIV Research: A Look Ahead to 2026"],"prefix":"10.1093","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7925-0488","authenticated-orcid":false,"given":"Geri R","family":"Donenberg","sequence":"first","affiliation":[{"name":"Office of the Director, Office of AIDS Research, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W","family":"Eisinger","sequence":"additional","affiliation":[{"name":"Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2026051419573981700_jiag062-B1","author":"Joint United Nations Programme on HIV\/AIDS"},{"key":"2026051419573981700_jiag062-B2","author":"U.S. Centers for Disease Control and Prevention"},{"key":"2026051419573981700_jiag062-B3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","article-title":"Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial","volume":"399","author":"Delany-Moretlwe","year":"2022","journal-title":"Lancet"},{"key":"2026051419573981700_jiag062-B4","author":"U.S. Department of Health and Human Services"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag062\/66712676\/jiag062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/5\/e1092\/66712676\/jiag062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/5\/e1092\/66712676\/jiag062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:57:44Z","timestamp":1778803064000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/233\/5\/e1092\/8455649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":4,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag062","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,15]]},"published":{"date-parts":[[2026,2,2]]}}}